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hypothalamus using in vivo 1H MRS at 14.1T
Hongxia Leia,b*, Carol Poitry-Yamatea, Fre´de´ric Preitnerc,
Bernard Thorensc and Rolf Gruettera,b,dThe hypothalamus plays an essential role in the cenNMR Biomtral nervous system of mammals by among others regulating
glucose homeostasis, food intake, temperature, and to some extent blood pressure. Assessments of hypothalamic
metabolism using, e.g. 1HMRS inmousemodels can provide important insights into its function. To date, direct in vivo
1H MRS measurements of hypothalamus have not been reported. Here, we report that in vivo single voxel
measurements of mouse hypothalamus are feasible using 1H MRS at 14.1T. Localized 1H MR spectra from hypo-
thalamus were obtained unilaterally (2–2.2mL, VOI) and bilaterally (4–4.4mL) with a quality comparable to that of
hippocampus (3–3.5mL). Using LCModel, a neurochemical profile consisting of 21metabolites was quantified for both
hypothalamus and hippocampus with most of the Crame´r-Rao lower bounds within 20%. Relative to the hippo-
campus, the hypothalamus was characterized by high g-aminobutryric acid and myo-inositol, and low taurine
concentrations. When studying transgenic mice with no glucose transporter isoform 8 expressed, small metabolic
changes were observed, yet glucose homeostasis was well maintained. We conclude that a specific neurochemical
profile of mouse hypothalamus can be measured by 1H MRS which will allow identifying and following metabolic
alterations longitudinally in the hypothalamus of genetic modified models. Copyright 2010 JohnWiley & Sons, Ltd.
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The hypothalamus has been intensively studied because of its
important role in the central nervous system linking the central
nervous system to the endocrine system via the pituitary gland,
such as co-ordinating hormonal and behavioral circadian rhythms,
neuroendocrine regulation, and governing emotional behavior
((1,2) and references therein). In addition, the orchestration and
control of glucose and energy homoeostasis by the hypothalamus
makes this brain region central to physiological and metabolic
studies ((3) and references therein). The use of experimental
models, particularly transgenic mouse models, is of great interest
for elucidating the multiple functions of the hypothalamus and
stands to benefit from non-invasive in vivo studies.
MRI and MRS have been shown to be powerful investigation
tools for non-invasive studies. In particular, 1H MRS has been
shown capable of measuring a neurochemical profile consisting
of 18 metabolites including neurotransmitters and energy
substrates from mouse striatum, cortex, thalamus, hippocampus
and cerebellum (4), but the measurement of smaller and deep
lying structures, such as the hypothalamus, has not yet been
reported. Both the location of the hypothalamus in the brain and
its small volume represent formidable challenges for 1H MRS.
High magnetic fields increases sensitivity, spectral resolution
and consequently lead to lower Crame´r-Rao lower bounds
(CRLBs) (5). For example, the intrinsically increased sensitivity
allowed detecting progressively lowered spectral signal intensi-
ties due to ischemia-induced cellular death in mouse striatum (6).
In this study, we report that such technical improvements
allowed in vivo, single voxel measurements of the neurochemical
profile from mouse hypothalamus at 14.1T. Furthermore, weed. 2010; 23: 578–583 Copyright  2010 John Wiley & Sons, Ltd.
1H MRS OF MOUSE HYPOTHALAMUS IN VIVOexamined quantitatively the effect of deleting the glucose
transporter protein isoform 8 (GLUT8) on the neurochemical
constituents including glucose of both hippocampus and
hypothalamus, in both of which GLUT8 is normally expressed
and highly involved (7,8).5METHODS
Animal protocols
Three groups of mice were studied with approval by the local
ethics committee. In the first group, eight adult C57BL/6 male
mice (29 4 g, Charles River, L’Arbresle Cedex, France) were
studied to evaluate the feasibility of 1H MRS measurements of
hypothalamus, as described below. GLUT8 knockout mice (GLUT8
KO) were backcrossed in the C57BL6/J@RJ background, which
were originally from Janvier, le Genest St. Isle, France, thereafter
internally bred at the Center for Integrative Genomics, University
of Lausanne, Switzerland. Six GLUT8 KOmice and six control mice
were subjected to the MR measurements at age of 12–14 weeks.
For MR studies, anesthesia was induced with 3% isoflurane
mixed with O2 and thereafter maintained with 0.8 1.5%
isoflurane. Right after stereotaxic fixation in a holder (RAPID
Biomedical GmbH, Rimpar, Gemany), the animal underwent
MR studies while breathing patterns and temperature were
monitored through a MR-compatible system (Model 1025, SA
Instruments Inc., Stony Brook, NY, US). Rectal temperature was
maintained at 368C by circulating warm water.
Magnetic Resonance instruments
All MR studies were carried out in a horizontal, 14.1T/26 cm magnet
(Magnex Scientific, Abingdon, UK), with a 12-cm-inner-diameter
gradient (400mT/m in 200ms), and 2nd order shim coils with
maximum strengths of Z2¼ 5.3 102mT/cm2, YZ¼ 1.2 101mT/
cm2, XZ¼ 1.2 101mT/cm2, XY¼ 4.5 102mT/cm2 and X2Y2¼
4.2 102mT/cm2 (Varian/Magnex Scientific, UK), interfaced to a
DirectDrive console (Varian Inc., Palo Alto, CA, US). A home-built
quadrature surface coil with twogeometrically decoupled single-turn
loops (12mm inner-diameter) resonating at 600-MHz radio
frequency (RF) was used as RF transceiver (9).
For localization and identification of anatomical landmarks,
multi-slice T2-weighted images were acquired using the fast spin
echo (FSE) technique (10) with a field of view of 20 20mm2,
2562 data matrix, 0.6-mm slice thickness, effective TE¼ 50ms and
TR¼ 6000ms. Thereafter, all 1st and 2nd order shim terms were
adjusted over the respective VOI using the echo-planar version of
FASTMAP (11), which resulted in water linewidths within 25Hz.
Localized 1H MR spectra were acquired using SPECIAL (12), using
TE/TR¼ 2.8/4,000ms in combination with outer volume suppres-
sion and VAPOR water suppression (13). To obtain adquate
signal-to-noise ratio (SNR), 320 or 480 scans were acquired for
unilateral hippocampus or bilateral hypothalamus, respectively.
To assess the potential partial volume effect of the 3rd ventricle
on measuring the neurochemical profile from the bilateral
hypothalamus, we simultaneously measured localized MR
spectra of unilateral hypothalamus (1 1 2–1 1.2 2.2mm3)
in five of the eight mice using 640 averages. For absolute
quantification, water signal was acquired using identical
parameters, except without water suppression and averaging
eight scans.NMR Biomed. 2010; 23: 578–583 Copyright  2010 John WileyQuantification and statistics
The in vivo 1H MR spectra obtained were processed as described
previously (4). A linear combination analysis method, LCModel (14)
was used to calculate metabolite concentrations from a fit to the
experimental spectrum based on known spectra of metabolites
(basis set), in combination with referencing to the corresponding
endogenous water signal (100% visibility andmolarities of 55.5mol/
L) (15). Absolute quantification was accomplished assuming 80%
brain water content, which allowed comparison to previous studies
performed under similar assumptions and conditions (4). In this
study, all metabolites except macromolecules (Mac) in the basis set
of the LCModel were simulated, i.e. alanine (Ala), ascorbate (Asc),
aspartate (Asp), creatine (Cr),myo-inositol (myo-Ins), g-aminobutryric
acid (GABA), glucose (Glc), glutamine (Gln), glutamate (Glu), glycine
(Gly), glycerophoshocholine (GPC), glutathione (GSH), lactate (Lac),
N-acetyl-aspartate (NAA), N-acetyl-aspartyl-glutamate (NAAG), phos-
phocholine (PCho), phosphocreatine (PCr), phosphorylethanola-
mine (PE), scyllo-inositol (Scyllo), and taurine (Tau). Mac was
measured in a volume including hypothalamus of one mouse
(C57BL/6) using an inversion recovery technique (TE/TI/TR¼ 2.8/
750/2500ms), processed and included in the basis set as described
previously (5). Thereafter, Macwas assumed to haveminimal pattern
difference between either regions or strains. Measurements with
CRLB> 50% were considered not detectable. Since GPC and PCho
were strongly correlated in the LCModel analysis (r¼0.8), the sum
of GPC and PCho was evaluated.
All data are presented as mean SD. Two-tailed student t-tests
were applied to perform statistical analysis. In particular, a paired
t-test was applied for comparing data acquired from different
brain regions in the same animals, and for comparing the
difference between unilateral and bilateral hypothalamus. To
correct for multiple comparisons, p-value thresholds p< 0.01
(),p< 0.002 (),p< 0.0002() were used to determine statistical
significance. Based on Bonferroni correction, the latter two p
value thresholds were considered suitable for 25 comparisons.RESULTS
Multi-slice FSE T2-weighted images at 14.1T provided adequate
spatial resolution and anatomical contrast for accurate position-
ing of the VOIs, in particular in the hippocampus and the
hypothalamus based on anatomical landmarks (Fig. 1). The field
inhomogeneities were compensated locally without exceeding
50% of the maximum strengths of the supplied 2nd order shim
coils, i.e. 47% in hypothalamus (Z2 1.5 102mT/cm2, YZ 1.9
102mT/cm2, XZ 5.6 102mT/cm2, XY 1.3 102mT/cm2 and
X2Y2 2.0 102mT/cm2) and 34% in hippocampus (Z2 1.6
102mT/cm2, YZ 2.1 102mT/cm2, XZ 3.6 102mT/cm2,
XY 1.3 102mT/cm2 and X2Y2 1.4 102mT/cm2). VAPOR
water suppression resulted in a residual water signal below NAA
and total creatine (Crþ PCr). As a result, 1H MR spectra of
hypothalamus were obtained with metabolite linewidths of
17 2Hz along with extracerebral lipid contamination at
1.3–1.7 ppm effectively eliminated, and comparable to those of
hippocampus, measured with metabolite linewidths of 16 3Hz
(Fig. 1). The corresponding SNRs of the spectra from hypothala-
mus were 14 1, similar to those from hippocampus, i.e. 14 4.
When comparing the 1H MR spectra of hypothalamus with
those of hippocampus, striking differences were apparent, such
as the elevated GABA and GPCþ PCho peaks, and the lower Ala,
Glu, Tau, myo-Ins and PCrþCr signal intensities (Fig. 1). LCModel& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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Figure 1. Typical multi-slice FSE images and localized 1HMR spectra of hippocampus and hypothalamus at 14T in onemouse. Spectra (TE/TR¼ 2.8/4000
msec) were obtained from the indicated VOIs (marked red for hippocampus (NT¼ 320) and yellow for hypothalamus (NT¼ 480)), and shown with
Gaussian apodization (gf¼ 0.15 sec). Relative to the hippocampus, the striking spectral features of hypothalamus are indicated with the oriented arrows
along the corresponding metabolites.
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0quantification of the 1H MR spectra from the hippocampus
resulted in 21 individual metabolite concentrations with minimal
fit residuals, extending the previously reported number of
metabolites (4) to the addition of Asc, Asp (in five out of eight
animals), Gly and Scyllo (Fig. 2). Most metabolite concentrations
were similar to previous results (4), but reduced CRLBs. In
addition, choline compounds, GPC and PCho, were quantified
separately with CRLBs mostly within 35%. Likewise, the
neurochemical profile of bilateral hypothalamus was obtained
where nearly all metabolites, including GPC, were quantified with
CRLBs< 20% and mostly with CRLBs< 15%. Due to the
comparatively decreased concentrations in hypothalamus, Ala
and Scyllo were quantified in four animals with CRLBs< 50%
(Fig. 2). Across all metabolite concentrations in hypothalamus,
the average CRLBs was no more than 0.35mmol/g (Fig. 2).
Relative to the hippocampus, the neurochemical profile of
hypothalamus had significantly lower Ala, Cr, Glu, NAA, PCr and
Tau contents, and increased GABA, GPC, GPCþ PCho, myo-Ins
and PE concentrations (Fig. 2). After correcting for multiple
comparisons, regional differences in the neurochemical profile
of hypothalamus were found in Ala, Cr, GABA, Glu, GPC,
GPCþ PCho, myo-Ins, NAA, PE and Tau, in agreement with the
apparent signal difference visually observed in the spectra
(Fig. 1).www.interscience.wiley.com/journal/nbm Copyright  201To determine whether potential partial volume effects from the
3rd ventricle [10% reported by Ma et al. 2008 (16)] may affect
absolute quantification, 1H MR spectra of unilateral hypothala-
mus were measured. The 1H MRS measurement of unilateral
hypothalamus excluding the 3rd ventricle did not present any
discernable signal discrepancy or quality reduction in spectra
when compared with spectra of bilateral hypothalamus from the
same animal (Fig. 3a). The resulting average metabolic linewidth
of 17 1Hz from unilateral hypothalamus was nearly identical to
that from bilateral hypothalamus, i.e. 17 2Hz. By increasing the
number of averages, the SNR was 10 1 and remained sufficient
to measure nearly all metabolites quantifiable within
CRLBs< 50% except for Ala and Scyllo. Concentrations obtained
from unilateral hypothalamus were not different from those of
bilateral hypothalamus (Fig. 3). In particular, NAA and Mac were
unaltered (Fig. 3b). Of the highly concentrated metabolites, only
Tau and the sum of Cr and PCr were increased by more than 10%
with p¼ 0.01 and p¼ 0.03 respectively.
In the animals with deletion of GLUT8, we noted that most
metabolites were unaffected (p> 0.05, Fig. 4) when compared to
their wild-type counterparts (unpaired student t-test), with the
exception of a slight increase in the total of PCr and Cr (p¼ 0.02)
and Tau (p¼ 0.04) in hippocampus and a small reduction of Gln
in hypothalamus (p¼ 0.02).0 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 578–583
Figure 3. Comparison of spectra and selected metabolites measured
bilaterally (white bars) and unilaterally hypothalamus (black bars) in
mouse hypothalamus. In (a), bilateral (VOI¼ 4.2mL, 420 scans) and
unilateral (VOI¼ 2.2mL, 680 scans) MR spectra from one mouse hypo-
thalamus were compared. Both spectra were processed to achieve an
identical linewidth by Gaussian apodization (gf¼ 0.08 sec). No apparent
difference was visually observed in the spectra (a) and thereafter con-
firmed by direct subtraction of the spectrum from the bilateral hypo-
thalamus from that of the unilateral hypothalamus [the trace labeled as
‘difference’ in (a)]. In (b), comparison of the neurochemical profile was
displayed between uni- (black bars) and bilateral hypothalamus (white
bars).
Figure 4. The neurochemical profile of hippocampus (a) and hypothala-
mus (b) in GLUT8 KO (black bars) and wild type mice (C57BL6/J@RJ, white
bars). Error bars are SDs.
Figure 2. Neurochemical profiles of mouse hypothalamus and hippo-
campus. In (a), the neurochemical profiles of hippocampus (white bars)
and hypothalamus (solid bars) are shown along with the observed
significant differences (‘’p< 0.01, ‘’p< 0.002 and ‘’p< 0.0002 (paired
student t-test)). The corresponding CRLBs for each metabolite are shown
in % [panel (b)] and mmol/g [Panel (c)] respectively.
1H MRS OF MOUSE HYPOTHALAMUS IN VIVO
5DISCUSSION
In this study, high quality spectra (high spectral resolution, sufficient
SNR, excellent localization performance, efficient water suppres-
sion) were reproducibly obtained from mouse hypothalamus. This
was achieved despite challenges due to the small mouse brain itself
and due to the distant location of the hypothalamus. Nearly
21 metabolites were reliably quantified and thus substantial
metabolic information of mouse hypothalamus was obtained
in vivo. To our knowledge, this study is the first in vivo, single voxel
measurement of the neurochemical profile of mouse hypothala-
mus.
With increased magnetic field strength, the intrinsically
amplified susceptibility differences in mouse brain between
surrounding air and tissue can be minimized by means of
automatic shimming methods (11), especially important for
hypothalamus where nearly identical metabolic linewidths were
achieved as those in hippocampus without exceeding any shim
strength limitations (see Results). The resulting linewidths did not
change with the size of VOIs and were slightly broader than
previous rat studies (5) but within the reported range of mouse
striatum (6) at the same field strength, which could be explained
by either limitations of 3rd or higher order shim terms or by
possible physiological contributions. Nonetheless, a very high
spectral resolution in both hippocampus and hypothalamus was
reproducibly accomplished as is illustrated in Figure 1.
Along with the increased distance of the hypothalamus from
the surface RF coil used here relative to that of the hippocampus,
the reduced sensitivity was partially compensated by means ofNMR Biomed. 2010; 23: 578–583 Copyright  2010 John Wileyusing a spin-echo full intensity localizing technique and by
slightly increasing total scan time. The resulting SNRs from
bilateral hypothalamus (4–4.4mL) in a reasonable measuring
time (30min) were nearly identical to those from unilateral
hippocampus (3mL) acquired in 20min. The sensitivity at 14.1T& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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2provided SNR 14 from both VOIs (Fig. 2). Even with 40-min
acquisition time, the resulting SNRs of the MR spectra acquired
from the unilateral hypothalamus (2–2.4mL) remained sufficient
for absolute quantification of most metabolites, as in previous
studies (6). It is of interest to note, that for 1H MRS at, e.g. 9.4T (4),
the estimated 50% reduced sensitivity compared to 14.1T (5) can
be compensated by approximately doubling the total scan time,
which may not be practical for many applications.
In all measurements, characteristic features of hypothalamic
metabolite concentrations were observed relative to those in
hippocampus, such as high concentrations of myo-Ins and GABA
and low Tau content. None of these concentration differences
would be explained by the presence of altered concentrations of
other compounds, such as Mac, since it was highly unlikely for
Mac to contribute all spectral changes in both Tau and GABA
(Fig. 1). In addition, these hallmarks of hypothalamic concen-
trations were consistent with previously reported biochemical
values in rats (17) and mice (18,19), in particular the high GABA
and low Glu concentrations, which could point to GABA as a
dominant neurotransmitter in hypothalamus (20). Furthermore,
the observed increased hypothalamic choline content mostly in
the form of GPC was in excellent agreement with chromato-
graphic measurements in mice (21).
When comparing bilateral to unilateral hypothalamus, we found
that the metabolite concentrations were highly consistent (Fig. 3).
This suggested that measuring bilateral hypothalamus can be
achieved with minimal partial volume effects from CSF in the 3rd
ventricle. For example, when assuming a 10–25% of CSF volume in
bilateral hypothalamus VOI (16), the water content used to quantify
metabolites should increase only by 2–5% since normal brain
already has 80% water content. Therefore, the concentrations
would increase by 2–5%, which will not change the main
conclusion of the present study that a neurochemical profile
specific to the unilateral hypothalamus can be measured in vivo.
It is interesting to note that the Glc content measured in
hypothalamus was nearly identical to that in hippocampus
(Fig. 2), suggesting that glucose homeostasis in hypothalamus
was similar to that of the hippocampus. This is consistent with the
presence of an intact blood–brain barrier, in agreement with a
recent biochemical study in rats (22).
Animals devoid of GLUT8 did not present any significant changes
when compared with the age-matched wild-type controls
suggesting that glucose homeostasis was well-maintained in
hippocampus and hypothalamus of GLUT8 KO animals (Fig. 4).
Nonetheless, small changes in the observed neurochemical profiles
of GLUT8 KO mice were found in the sum of PCr and Cr, and Tau in
hippocampus, and hypothalamic Gln. Therefore, themeasured 50%
increase of cell proliferation in hippocampus in GLUT8 KO mice at
the same age (7) could be a possible explanation for retaining the
apparent normal neurochemical profile and similar glucose
contents.
In the present study we assumed that the signal from Mac did
not vary substantially from region to region or due to genetic
modifications. The assumed unaltered patterns of Mac was further
supported by LCModel analysis from the minimal fit residuals, as
demonstrated in Results. In addition, the attributes of hypothala-
mus relative to the hippocampus, such as low Tau and high GABA
contents as determined by LCModel were visually striking in theMR
spectra (Fig. 1). Nonetheless, the main conclusion of the present
paper, namely that assessing the neurochemical profile of mouse
hypothalamus in vivo using 1H MRS is feasible, is not affected by
these considerations.www.interscience.wiley.com/journal/nbm Copyright  201We conclude that localized 1H MRS of mouse hypothalamus
in vivo is feasible at high magnetic fields. This novel technique
opens new possibilities to study this important brain region in
genetic models of disease.Acknowledgements
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